BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 30356287)

  • 1. Cross-sectional estimates revealed high HIV incidence in Botswana rural communities in the era of successful ART scale-up in 2013-2015.
    Moyo S; Gaseitsiwe S; Mohammed T; Pretorius Holme M; Wang R; Kotokwe KP; Boleo C; Mupfumi L; Yankinda EK; Chakalisa U; van Widenfelt E; Gaolathe T; Mmalane MO; Dryden-Peterson S; Mine M; Lebelonyane R; Bennett K; Leidner J; Wirth KE; Tchetgen Tchetgen E; Powis K; Moore J; Clarke WA; Lockman S; Makhema JM; Essex M; Novitsky V
    PLoS One; 2018; 13(10):e0204840. PubMed ID: 30356287
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Field Validation of Limiting-Antigen Avidity Enzyme Immunoassay to Estimate HIV-1 Incidence in Cross-Sectional Survey in Swaziland.
    Duong YT; Dobbs T; Mavengere Y; Manjengwa J; Rottinghaus E; Saito S; Bock N; Philip N; Justman J; Bicego G; Nkengasong JN; Parekh BS
    AIDS Res Hum Retroviruses; 2019 Oct; 35(10):896-905. PubMed ID: 31204867
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Botswana's progress toward achieving the 2020 UNAIDS 90-90-90 antiretroviral therapy and virological suppression goals: a population-based survey.
    Gaolathe T; Wirth KE; Holme MP; Makhema J; Moyo S; Chakalisa U; Yankinda EK; Lei Q; Mmalane M; Novitsky V; Okui L; van Widenfelt E; Powis KM; Khan N; Bennett K; Bussmann H; Dryden-Peterson S; Lebelonyane R; El-Halabi S; Mills LA; Marukutira T; Wang R; Tchetgen EJ; DeGruttola V; Essex M; Lockman S;
    Lancet HIV; 2016 May; 3(5):e221-30. PubMed ID: 27126489
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Short Communication: Low False Recent Rate of Limiting Antigen-Avidity Assay Combined with HIV-1 RNA Data in Botswana.
    Moyo S; Kotokwe KP; Mohammed T; Boleo C; Mupfumi L; Chishala S; Tsalaile L; Bussmann H; Gaseitsiwe S; Musonda R; Makhema J; Baum M; Marlink R; Engelbrecht S; Essex M; Novitsky V
    AIDS Res Hum Retroviruses; 2017 Jan; 33(1):17-18. PubMed ID: 27481530
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Estimating HIV incidence in the Akwa Ibom AIDS indicator survey (AKAIS), Nigeria using the limiting antigen avidity recency assay.
    Negedu-Momoh OR; Balogun O; Dafa I; Etuk A; Oladele EA; Adedokun O; James E; Pandey SR; Khamofu H; Badru T; Robinson J; Mastro TD; Torpey K
    J Int AIDS Soc; 2021 Feb; 24(2):e25669. PubMed ID: 33619853
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Towards achieving the 90-90-90 HIV targets: results from the south African 2017 national HIV survey.
    Marinda E; Simbayi L; Zuma K; Zungu N; Moyo S; Kondlo L; Jooste S; Nadol P; Igumbor E; Dietrich C; Briggs-Hagen M
    BMC Public Health; 2020 Sep; 20(1):1375. PubMed ID: 32907565
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Progress towards the UNAIDS 95-95-95 targets in the Fifth Botswana AIDS Impact Survey (BAIS V 2021): a nationally representative survey.
    Mine M; Stafford KA; Laws RL; Marima R; Lekone P; Ramaabya D; Makhaola K; Patel HK; Mapondera P; Wray-Gordon F; Agbakwuru C; Okui L; Matroos S; Onyadile E; Ngidi J; Abimiku A; Bagapi K; Nkomo B; Bodika SM; Kim KJ; Moloney M; Mitchell A; Ehoche A; Ussery FL; Hong SY; Keipeile S; Matlhaga M; Mathumo R; Selato R; Charurat ME; Voetsch AC
    Lancet HIV; 2024 Apr; 11(4):e245-e254. PubMed ID: 38467135
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of Early Antiretroviral Treatment Initiation on Performance of Cross-Sectional Incidence Assays.
    Klock E; Mwinnya G; Eller LA; Fernandez RE; Kibuuka H; Nitayaphan S; Kosgei J; Moore RD; Robb M; Eshleman SH; Laeyendecker O
    AIDS Res Hum Retroviruses; 2020 Jul; 36(7):583-589. PubMed ID: 32295382
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Population uptake of HIV testing, treatment, viral suppression, and male circumcision following a community-based intervention in Botswana (Ya Tsie/BCPP): a cluster-randomised trial.
    Wirth KE; Gaolathe T; Pretorius Holme M; Mmalane M; Kadima E; Chakalisa U; Manyake K; Matildah Mbikiwa A; Simon SV; Letlhogile R; Mukokomani K; van Widenfelt E; Moyo S; Bennett K; Leidner J; Powis KM; Lebelonyane R; Alwano MG; Jarvis J; Dryden-Peterson SL; Kgathi C; Moore J; Bachanas P; Raizes E; Abrams W; Block L; Sento B; Novitsky V; El-Halabi S; Marukutira T; Mills LA; Sexton C; Pals S; Shapiro RL; Wang R; Lei Q; DeGruttola V; Makhema J; Essex M; Lockman S; Tchetgen Tchetgen EJ
    Lancet HIV; 2020 Jun; 7(6):e422-e433. PubMed ID: 32504575
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development and Evaluation of a Modified Fourth-Generation Human Immunodeficiency Virus Enzyme Immunoassay for Cross-Sectional Incidence Estimation in Clade B Populations.
    Kirkpatrick AR; Patel EU; Celum CL; Moore RD; Blankson JN; Mehta SH; Kirk GD; Margolick JB; Quinn TC; Eshleman SH; Laeyendecker O
    AIDS Res Hum Retroviruses; 2016 Aug; 32(8):756-62. PubMed ID: 26988426
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Successes and gaps in the HIV cascade of care of a high HIV prevalence setting in Zimbabwe: a population-based survey.
    Conan N; Coulborn RM; Simons E; Mapfumo A; Apollo T; Garone DB; Casas EC; Puren AJ; Chihana ML; Maman D
    J Int AIDS Soc; 2020 Sep; 23(9):e25613. PubMed ID: 32969602
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A comparison of self-report and antiretroviral detection to inform estimates of antiretroviral therapy coverage, viral load suppression and HIV incidence in Kwazulu-Natal, South Africa.
    Huerga H; Shiferie F; Grebe E; Giuliani R; Farhat JB; Van-Cutsem G; Cohen K
    BMC Infect Dis; 2017 Sep; 17(1):653. PubMed ID: 28969607
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Detection of recent HIV-1 infection using a new limiting-antigen avidity assay: potential for HIV-1 incidence estimates and avidity maturation studies.
    Duong YT; Qiu M; De AK; Jackson K; Dobbs T; Kim AA; Nkengasong JN; Parekh BS
    PLoS One; 2012; 7(3):e33328. PubMed ID: 22479384
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Short Communication: Assessing Estimates of HIV Incidence with a Recent Infection Testing Algorithm That Includes Viral Load Testing and Exposure to Antiretroviral Therapy.
    Kim AA; Rehle T
    AIDS Res Hum Retroviruses; 2018 Oct; 34(10):863-866. PubMed ID: 29926735
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of the false recent classification rates of multiassay algorithms in estimating HIV type 1 subtype C incidence.
    Moyo S; LeCuyer T; Wang R; Gaseitsiwe S; Weng J; Musonda R; Bussmann H; Mine M; Engelbrecht S; Makhema J; Marlink R; Baum MK; Novitsky V; Essex M
    AIDS Res Hum Retroviruses; 2014 Jan; 30(1):29-36. PubMed ID: 23937344
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Performance comparison of the Maxim and Sedia Limiting Antigen Avidity assays for HIV incidence surveillance.
    Sempa JB; Welte A; Busch MP; Hall J; Hampton D; Facente SN; Keating SM; Marson K; Parkin N; Pilcher CD; Murphy G; Grebe E;
    PLoS One; 2019; 14(7):e0220345. PubMed ID: 31348809
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Universal Testing, Expanded Treatment, and Incidence of HIV Infection in Botswana.
    Makhema J; Wirth KE; Pretorius Holme M; Gaolathe T; Mmalane M; Kadima E; Chakalisa U; Bennett K; Leidner J; Manyake K; Mbikiwa AM; Simon SV; Letlhogile R; Mukokomani K; van Widenfelt E; Moyo S; Lebelonyane R; Alwano MG; Powis KM; Dryden-Peterson SL; Kgathi C; Novitsky V; Moore J; Bachanas P; Abrams W; Block L; El-Halabi S; Marukutira T; Mills LA; Sexton C; Raizes E; Gaseitsiwe S; Bussmann H; Okui L; John O; Shapiro RL; Pals S; Michael H; Roland M; DeGruttola V; Lei Q; Wang R; Tchetgen Tchetgen E; Essex M; Lockman S
    N Engl J Med; 2019 Jul; 381(3):230-242. PubMed ID: 31314967
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Undisclosed antiretroviral drug use in Botswana: implication for national estimates.
    Moyo S; Gaseitsiwe S; Powis KM; Pretorius Holme M; Mohammed T; Zahralban-Steele M; Yankinde EK; Maphorisa C; Abrams W; Lebelonyane R; Manyake K; Sekoto T; Mmalane M; Gaolathe T; Wirth KE; Makhema J; Lockman S; Clarke W; Essex M; Novitsky V
    AIDS; 2018 Jul; 32(11):1543-1546. PubMed ID: 29762166
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Improved testing of recent HIV-1 infections with the BioRad avidity assay compared to the limiting antigen avidity assay and BED Capture enzyme immunoassay: evaluation using reference sample panels from the German Seroconverter Cohort.
    Hauser A; Santos-Hoevener C; Meixenberger K; Zimmermann R; Somogyi S; Fiedler S; Hofmann A; Bartmeyer B; Jansen K; Hamouda O; Bannert N; Kuecherer C
    PLoS One; 2014; 9(6):e98038. PubMed ID: 24892795
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of HIV Incidence in the Zimbabwe Population-Based HIV Impact Assessment Survey (2015-2016) with Modeled Estimates: Progress Toward Epidemic Control.
    Gonese E; Musuka G; Ruangtragool L; Hakim A; Parekh B; Dobbs T; Duong YT; Patel H; Mhangara M; Mugurungi O; Mapingure M; Saito S; Herman-Roloff A; Gwanzura L; Tippett-Barr B; Kilmarx PH; Justman J
    AIDS Res Hum Retroviruses; 2020 Aug; 36(8):656-662. PubMed ID: 32498542
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.